Now, here is Human Longevity Inc., which has a much more scientific background for doing the same.
Human Longevity Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, was announced today by co-founders J. Craig Venter, Ph.D., Robert Hariri, M.D., Ph.D., and Peter H. Diamandis, M.D.
The company, headquartered in San Diego, California, is being capitalized with an initial $70 million in investor funding.
It will also involve the biggest genome sequencing effort in history with the aim of sequencing the genomes of 100 000 people every year! Let’s follow them closely!